Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial
Titel:
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial
Auteur:
Carles, Joan Alonso-Gordoa, Teresa Mellado, Begoña Méndez-Vidal, María J. Vázquez, Sergio González-del-Alba, Aránzazu Piulats, Josep M. Borrega, Pablo Gallardo, Enrique Morales-Barrera, Rafael Paredes, Pilar Reig, Oscar Garcías de España, Carmen Collado, Ricardo Bonfill, Teresa Suárez, Cristina Sampayo-Cordero, Miguel Malfettone, Andrea Garde, Javier